397 related articles for article (PubMed ID: 20351703)
1. Marfan syndrome. Part 1: pathophysiology and diagnosis.
Cañadas V; Vilacosta I; Bruna I; Fuster V
Nat Rev Cardiol; 2010 May; 7(5):256-65. PubMed ID: 20351703
[TBL] [Abstract][Full Text] [Related]
2. The molecular genetics of Marfan syndrome and related disorders.
Robinson PN; Arteaga-Solis E; Baldock C; Collod-Béroud G; Booms P; De Paepe A; Dietz HC; Guo G; Handford PA; Judge DP; Kielty CM; Loeys B; Milewicz DM; Ney A; Ramirez F; Reinhardt DP; Tiedemann K; Whiteman P; Godfrey M
J Med Genet; 2006 Oct; 43(10):769-87. PubMed ID: 16571647
[TBL] [Abstract][Full Text] [Related]
3. Genetic fibrillinopathies: new insights in molecular diagnosis and clinical management.
Loeys BL; Matthys DM; de Paepe AM
Acta Clin Belg; 2003; 58(1):3-11. PubMed ID: 12723256
[TBL] [Abstract][Full Text] [Related]
4. Ascending aortic aneurysm with or without features of Marfan syndrome and other fibrillinopathies: new insights.
Furthmayr H; Francke U
Semin Thorac Cardiovasc Surg; 1997 Jul; 9(3):191-205. PubMed ID: 9263339
[TBL] [Abstract][Full Text] [Related]
5. Marfan syndrome and fibrillin disorders.
Le Parc JM; Molcard S; Tubach F; Boileau C; Jondeau G; Muti C; Chevallier B; Pisella PJ
Joint Bone Spine; 2000; 67(5):401-7. PubMed ID: 11143906
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular manifestations in Marfan syndrome and related diseases; multiple genes causing similar phenotypes.
Cook JR; Carta L; Galatioto J; Ramirez F
Clin Genet; 2015; 87(1):11-20. PubMed ID: 24867163
[TBL] [Abstract][Full Text] [Related]
7. The molecular genetics of Marfan syndrome and related microfibrillopathies.
Robinson PN; Godfrey M
J Med Genet; 2000 Jan; 37(1):9-25. PubMed ID: 10633129
[TBL] [Abstract][Full Text] [Related]
8. Dural ectasia and FBN1 mutation screening of 40 patients with Marfan syndrome and related disorders: role of dural ectasia for the diagnosis.
Attanasio M; Pratelli E; Porciani MC; Evangelisti L; Torricelli E; Pellicanò G; Abbate R; Gensini GF; Pepe G
Eur J Med Genet; 2013 Jul; 56(7):356-60. PubMed ID: 23684891
[TBL] [Abstract][Full Text] [Related]
9. The molecular pathogenesis of the Marfan syndrome.
Robinson PN; Booms P
Cell Mol Life Sci; 2001 Oct; 58(11):1698-707. PubMed ID: 11706995
[TBL] [Abstract][Full Text] [Related]
10. Marfan syndrome: new clues to genotype-phenotype correlations.
Ramirez F; Gayraud B; Pereira L
Ann Med; 1999 Jun; 31(3):202-7. PubMed ID: 10442675
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of dural ectasia in 63 gene-mutation-positive patients with features of Marfan syndrome type 1 and Loeys-Dietz syndrome and report of 22 novel FBN1 mutations.
Söylen B; Singh KK; Abuzainin A; Rommel K; Becker H; Arslan-Kirchner M; Schmidtke J
Clin Genet; 2009 Mar; 75(3):265-70. PubMed ID: 19159394
[TBL] [Abstract][Full Text] [Related]
12. Marfan syndrome type II: there is more to Marfan syndrome than fibrillin 1.
Zangwill SD; Brown MD; Bryke CR; Cava JR; Segura AD
Congenit Heart Dis; 2006 Sep; 1(5):229-32. PubMed ID: 18377530
[TBL] [Abstract][Full Text] [Related]
13. Fibrillin-1 mutations in Marfan syndrome and other type-1 fibrillinopathies.
Hayward C; Brock DJ
Hum Mutat; 1997; 10(6):415-23. PubMed ID: 9401003
[TBL] [Abstract][Full Text] [Related]
14. Fibrillin in Marfan syndrome and tight skin mice provides new insights into transforming growth factor-beta regulation and systemic sclerosis.
Lemaire R; Bayle J; Lafyatis R
Curr Opin Rheumatol; 2006 Nov; 18(6):582-7. PubMed ID: 17053502
[TBL] [Abstract][Full Text] [Related]
15. Engineered mutations in fibrillin-1 leading to Marfan syndrome act at the protein, cellular and organismal levels.
Zeyer KA; Reinhardt DP
Mutat Res Rev Mutat Res; 2015; 765():7-18. PubMed ID: 26281765
[TBL] [Abstract][Full Text] [Related]
16. Microfibrils: a cornerstone of extracellular matrix and a key to understand Marfan syndrome.
Bonetti MI
Ital J Anat Embryol; 2009; 114(4):201-24. PubMed ID: 20578676
[TBL] [Abstract][Full Text] [Related]
17. Recent progress in genetics of Marfan syndrome and Marfan-associated disorders.
Mizuguchi T; Matsumoto N
J Hum Genet; 2007; 52(1):1-12. PubMed ID: 17061023
[TBL] [Abstract][Full Text] [Related]
18. Antagonism of GxxPG fragments ameliorates manifestations of aortic disease in Marfan syndrome mice.
Guo G; Muñoz-García B; Ott CE; Grünhagen J; Mousa SA; Pletschacher A; von Kodolitsch Y; Knaus P; Robinson PN
Hum Mol Genet; 2013 Feb; 22(3):433-43. PubMed ID: 23100322
[TBL] [Abstract][Full Text] [Related]
19. Identification of defects in the fibrillin gene and protein in individuals with the Marfan syndrome and related disorders.
Milewicz DM
Tex Heart Inst J; 1994; 21(1):22-9. PubMed ID: 8180508
[TBL] [Abstract][Full Text] [Related]
20. Loss of elastic fiber integrity and reduction of vascular smooth muscle contraction resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in the thoracic aortic aneurysm in Marfan syndrome.
Chung AW; Au Yeung K; Sandor GG; Judge DP; Dietz HC; van Breemen C
Circ Res; 2007 Aug; 101(5):512-22. PubMed ID: 17641224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
